[Form 4] Liquidia Corporation Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Insider Trade Summary
Net Seller: 5,327 shares ($76,070)
Net Sell
3 txns
Insider
Saggar Rajeev
Role
Chief Medical Officer
Sold
5,327 shs ($76K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,327 | $14.28 | $76K |
| Exercise | Performance Stock Units | 3,531 | $0.00 | -- |
| Exercise | Common Stock | 3,531 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 271,413 shares (Direct);
Performance Stock Units — 35,307 shares (Direct)
Footnotes (1)
- Performance stock units ("PSUs") convert into common stock on a one-for-one basis. On January 11, 2024, the Reporting Person was granted 56,492 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs vesting ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 21,185 have vested as of the date of this Form 4. Includes (i) 5,865 unvested restricted stock units ("RSUs") of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 31,249 unvested RSUs of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (iii) 35,307 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iv) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (v) 6,291 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023. These shares were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023 and January 11, 2024.
